Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 6:9:865034.
doi: 10.3389/fmed.2022.865034. eCollection 2022.

Genotype-Phenotype Correlations for Pathogenic COL4A3-COL4A5 Variants in X-Linked, Autosomal Recessive, and Autosomal Dominant Alport Syndrome

Affiliations
Review

Genotype-Phenotype Correlations for Pathogenic COL4A3-COL4A5 Variants in X-Linked, Autosomal Recessive, and Autosomal Dominant Alport Syndrome

Judy Savige et al. Front Med (Lausanne). .

Abstract

Alport syndrome is inherited as an X-linked (XL), autosomal recessive (AR), or autosomal dominant (AD) disease, where pathogenic COL4A3 - COL4A5 variants affect the basement membrane collagen IV α3α4α5 network. About 50% of pathogenic variants in each gene (major rearrangements and large deletions in 15%, truncating variants in 20%, splicing changes in 15%) are associated with "severe" disease with earlier onset kidney failure, and hearing loss and ocular abnormalities in males with XL inheritance and in males and females with AR disease. Severe variants are also associated with early proteinuria which is itself a risk factor for kidney failure. The other half of pathogenic variants are missense changes which are mainly Gly substitutions. These are generally associated with later onset kidney failure, hearing loss, and less often with major ocular abnormalities. Further determinants of severity for missense variants for XL disease in males, and in AD disease, include Gly versus non-Gly substitutions; increased distance from a non-collagenous interruption or terminus; and Gly substitutions with a more (Arg, Glu, Asp, Val, and Trp) or less disruptive (Ala, Ser, and Cys) residue. Understanding genotype-phenotype correlations in Alport syndrome is important because they help predict the likely age at kidney failure, and the need for early and aggressive management with renin-angiotensin system blockade and other therapies. Genotype-phenotype correlations also help standardize patients with Alport syndrome undergoing trials of clinical treatment. It is unclear whether severe variants predispose more often to kidney cysts or coincidental IgA glomerulonephritis which are recognized increasingly in COL4A3-, COL4A4 - and COL4A5-associated disease.

Keywords: AD Alport syndrome; AR Alport syndrome; Alport syndrome; COL4A3; COL4A4; COL4A5; XL Alport syndrome; genotype-phenotype correlation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Collagen IV α3α4α5 heterotrimer demonstrating amino terminus, intermediate collagenous domain, and carboxy terminus. The intermediate collagenous domain comprises Gly-Xaa-Yaa repeats with multiple interruptions.

Similar articles

Cited by

References

    1. Grunfeld JP, Joly D. Hereditary kidney diseases in adults. Rev Prat. (1997) 47:1566–9. - PubMed
    1. Savige J, Gregory M, Gross O, Kashtan C, Ding J, Flinter F. Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol. (2013) 24:364–75. 10.1681/ASN.2012020148 - DOI - PubMed
    1. Savige J, Rana K, Tonna S, Buzza M, Dagher H, Wang YY. Thin basement membrane nephropathy. Kidney Int. (2003) 64:1169–78. 10.1046/j.1523-1755.2003.00234.x - DOI - PubMed
    1. Kashtan CE, Ding J, Garosi G, Heidet L, Massella L, Nakanishi K, et al. . Alport syndrome: a unified classification of genetic disorders of collagen IV alpha345: a position paper of the Alport Syndrome Classification Working Group. Kidney Int. (2018) 93:1045–51. 10.1016/j.kint.2017.12.018 - DOI - PubMed
    1. Furlano M, Martinez V, Pybus M, Arce Y, Crespi J, Venegas MDP, et al. . Clinical and genetic features of autosomal dominant Alport syndrome: a cohort study. Am J Kidney Dis. (2021) 78:560–70.e1. 10.1053/j.ajkd.2021.02.326 - DOI - PubMed